Cargando…
Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
Although efficacy of combined histone deacetylase (HDAC) inhibitors and conventional photon radiotherapy is being tested in clinical trials, their combined effect with proton beam radiotherapy has yet to be determined. Here, we compared combined effect of valproic acid (VPA), a class I and II HDAC i...
Autores principales: | Yu, Jeong Il, Choi, Changhoon, Shin, Sung-Won, Son, Arang, Lee, Ga-Haeng, Kim, Shin-Yeong, Park, Hee Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678087/ https://www.ncbi.nlm.nih.gov/pubmed/29118323 http://dx.doi.org/10.1038/s41598-017-15165-3 |
Ejemplares similares
-
Publisher Correction: Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
por: Yu, Jeong Il, et al.
Publicado: (2018) -
Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction
por: Choi, Changhoon, et al.
Publicado: (2019) -
Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells
por: Choi, Changhoon, et al.
Publicado: (2021) -
High-Throughput 3D Tumor Spheroid Array Platform for Evaluating Sensitivity of Proton-Drug Combinations
por: Lee, Dong Woo, et al.
Publicado: (2022) -
Therapeutic Potential of (−)-Agelamide D, a Diterpene Alkaloid from the Marine Sponge Agelas sp., as a Natural Radiosensitizer in Hepatocellular Carcinoma Models
por: Choi, Changhoon, et al.
Publicado: (2020)